Elanco
USA · Pharma & Healthcare
LeaveRussia detail: Scaling Back
Elanco Animal Health is an international pharmaceutical company specializing in veterinary drugs.
Decision trail
Decision date 18/03/2022 · Reference ↗
Scale back to critical products to ensure food security. Revenue decreased in 2024 vs 2023 by more than -20%.
Local stats (LeaveRussia)
Assets(RF), mln.USD
38
Capital(RF), mln.USD
33
Glob.Revenue, mln.USD
4417
Revenue(RF), mln.USD
39
Staff(RF), 2021
68
Taxes(RF), mln.USD
1
Status history since 2022
- 03/08/2026 — scaling back · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional